Education
About Us
Working with TipRanks
Follow Us
Heartbeam, Inc. (BEAT)
:BEAT
BEAT Stock Chart & Stats
$1.73
$0.00(0.00%)
At close: 4:00 PM EST
$1.73
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.91 - $3.48
Previous CloseN/A
Volume12.23K
Average Volume (3M)91.72K
Market Cap
$59.36M
Enterprise Value$37.24M
Total Cash (Recent Filing)$3.26M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.79
Next Earnings
Nov 06, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding34,311,590
10 Day Avg. Volume95,093
30 Day Avg. Volume91,723
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.63
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-1.69K
Enterprise Value/Ebitda-1.81
Forecast
1Y Price Target
$8.00Price Target Upside362.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Commercial LaunchHeartBeam is well prepared for a pilot commercial launch and a full launch in 2026.
FDA ClearanceHeartBeam's proprietary system for arrhythmia assessment has received FDA clearance for a cable-free, patient-held device with 12-lead ECG accuracy.
Strategic PartnershipsInbound interest from potential strategic partners has accelerated with discussions around data and AI, complementary diagnostics and treatments, and distribution.
Bears Say
Financial PerformanceCash used in operating activities was $4.5M, indicating significant expenses in the first quarter.
Funding NeedsManagement believes that cash on hand combined with interim financing alternatives are sufficient to fund operations through the upcoming 510(k) clearance.
HeartBeam News
BEAT FAQ
What was Heartbeam, Inc.’s price range in the past 12 months?
Heartbeam, Inc. lowest stock price was $0.91 and its highest was $3.48 in the past 12 months.
What is Heartbeam, Inc.’s market cap?
Heartbeam, Inc.’s market cap is $59.36M.
When is Heartbeam, Inc.’s upcoming earnings report date?
Heartbeam, Inc.’s upcoming earnings report date is Nov 06, 2025 which is in 19 days.
How were Heartbeam, Inc.’s earnings last quarter?
Heartbeam, Inc. released its earnings results on Aug 13, 2025. The company reported -$0.15 earnings per share for the quarter, beating the consensus estimate of -$0.16 by $0.01.
Is Heartbeam, Inc. overvalued?
According to Wall Street analysts Heartbeam, Inc.’s price is currently Undervalued.
Does Heartbeam, Inc. pay dividends?
Heartbeam, Inc. does not currently pay dividends.
What is Heartbeam, Inc.’s EPS estimate?
Heartbeam, Inc.’s EPS estimate is -0.12.
How many shares outstanding does Heartbeam, Inc. have?
Heartbeam, Inc. has 34,311,590 shares outstanding.
What happened to Heartbeam, Inc.’s price movement after its last earnings report?
Heartbeam, Inc. reported an EPS of -$0.15 in its last earnings report, beating expectations of -$0.16. Following the earnings report the stock price went down -7.5%.
Which hedge fund is a major shareholder of Heartbeam, Inc.?
Currently, no hedge funds are holding shares in BEAT
HeartBeam Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (362.43% Upside)
$8.00 (362.43% Upside)
Blogger Sentiment
Bullish
BEAT Sentiment 100%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-24.12%
12-Months-Change
Fundamentals
Return on Equity
-315.70%
Trailing 12-Months
Asset Growth
-40.93%
Trailing 12-Months
Company Description
Heartbeam, Inc.
HeartBeam, Inc. (BEAT) is a healthcare technology company focused on developing advanced solutions for cardiovascular disease detection and management. Operating in the medical device sector, the company specializes in creating innovative, portable, and easy-to-use heart monitoring products aimed at improving patient outcomes and reducing healthcare costs. Its core offerings include a proprietary system designed to enable users to take a 12-lead electrocardiogram (ECG) outside of a medical setting and transmit the data to healthcare providers.
BEAT Company Deck
BEAT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlights significant progress in regulatory approvals, commercial readiness, and strategic cash management, alongside industry recognition. However, challenges remain with pending FDA clearance and cash constraints.View all BEAT earnings summariesBEAT Stock 12 Month Forecast
Average Price Target
$8.00
▲(362.43% Upside)
Technical Analysis
Ownership Overview
14.92% Insiders
3.87% Mutual Funds
3.24% Other Institutional Investors
75.09% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---